Can AI help see chemo-related fatty liver?
Treatments studied
Part of Digestive system clinical trials.
This study uses a special MRI technique and artificial intelligence to see how chemotherapy may cause a fatty liver. It may help find liver changes early in people who have had chemo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You do not have fatty liver on a CT or ultrasound.
- You can safely have an MRI (no pacemaker, stent, metal, or claustrophobia).
- You have received chemotherapy before or after surgery (neoadjuvant or adjuvant).
- Your follow-up information is available.
- You do not have any other liver spots (like metastases or hemangioma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to help doctors identify fatty liver disease from CT scans you may already be having. If eligible, you'll have some blood tests and possibly an ultrasound or MRI to confirm liver health, helping catch liver disease early.
This study tests whether an AI tool can predict how well stomach cancer responds to chemotherapy before surgery. It uses CT scans and biopsy images taken before treatment starts to see if the AI can help guide future care.
This study tests whether an AI tool can help doctors read CT scans of the liver to find cancerous spots. If you have had a CT scan of your abdomen with specific timing, you might be able to join.
This study uses artificial intelligence to help doctors get clearer heart ultrasound images in people who have had chemotherapy that can affect the heart. If you already get these heart scans, the AI may help make them more accurate and faster.
This trial uses an AI system to help doctors plan surgery for liver cancer. It is for people who have had a CT scan of their liver and may or may not have a liver tumor.
This trial uses AI to analyze your pre-treatment MRI and predict how well your tumor will respond to chemotherapy before surgery. It is for people with HR+/HER2- breast cancer who need chemo before their operation.
Hear when a new Non-Alcoholic Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.